adenosine diphosphate has been researched along with (5-(3-thienyl)tetrazol-1-yl)acetic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamada, Y; Hara, T; Inukai, S; Koh, N; Nakamura, J; Nakashima, E; Naruse, K; Sakakibara, F; Sasaki, H; Takeuchi, N | 1 |
| Fukasawa, H; Hamada, Y; Hara, T; Hotta, N; Inukai, S; Kasama, N; Koh, N; Nakamura, J; Sakakibara, F; Takeuchi, N | 1 |
2 other study(ies) available for adenosine diphosphate and (5-(3-thienyl)tetrazol-1-yl)acetic acid
| Article | Year |
|---|---|
An aldose reductase inhibitor, TAT, reduces ADP-induced platelet hyperaggregation in streptozotocin-induced diabetic rats with neuropathy.
Topics: Adenosine Diphosphate; Aldehyde Reductase; Ampholyte Mixtures; Animals; Blood Glucose; Blood Platelets; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Enzyme Inhibitors; Male; Neural Conduction; Platelet Aggregation; Polymers; Rats; Rats, Wistar; Sciatic Nerve; Streptozocin; Tetrazoles; Thiophenes | 1995 |
An aldose reductase inhibitor, TAT, prevents electroretinographic abnormalities and ADP-induced hyperaggregability in streptozotocin-induced diabetic rats.
Topics: Adenosine Diphosphate; Aldehyde Reductase; Animals; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Electroretinography; Enzyme Inhibitors; Fructose; Glucose; Male; Platelet Aggregation; Rats; Rats, Sprague-Dawley; Retina; Sorbitol; Tetrazoles; Thiophenes | 1995 |